|

Azacitidine (AZA) Clinical Trials

10 actively recruiting trials across 5 locations

▼ -1 trial since August 2026

Also known as: Azadine, Onureg, VIDAZA, Vidaza

Pipeline

Phase 2: 5Phase 3: 2Phase 1/2: 3

Top Sponsors

  • Timothy Pardee1
  • The First Affiliated Hospital of Soochow University1
  • Technische Universität Dresden1
  • Sumitomo Pharma America, Inc.1
  • Ruijin Hospital1

Indications

  • Cancer10
  • Acute Myeloid Leukemia3
  • Leukemia, Myeloid, Acute2
  • Myelodysplastic Syndromes2
  • Leukemia, Lymphocytic, Acute1

Other5 trials

Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
Phase 2
Study of SA+X in the Treatment of Newly Diagnosed AML
Phase 2
Study to Evaluate the Safety and Tolerability of EP0042
Phase 1/2
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Phase 2
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
Phase 2

Birmingham, Alabama1 trial

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

University of Alabama at Birmingham

Phase 3

Gilbert, Arizona1 trial

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Banner MD Anderson Cancer Center

Phase 3

Newport Beach, California1 trial

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Hoag Family Cancer Center

Phase 1/2

Boston, Massachusetts1 trial

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

Brigham and Women's Hospital

Phase 1/2

Winston-Salem, North Carolina1 trial

Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax

Atrium Health Wake Forest Baptist Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.